Screener
Nektar Therapeutics NKTR Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares designated or outstanding at March 31, 2026 or December 31, 2025, respectively | — | — |
| Common stock, $0.0001 par value; 390,000,000 shares authorized; 29,472,092 shares and 20,378,832 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 3 | 2 |
| Capital in excess of par value | 4,382,437 | 3,850,099 |
| Accumulated other comprehensive income (loss) | (1,034) | 17 |
| Accumulated deficit | (3,805,190) | (3,760,286) |
| Total stockholders’ equity | 576,216 | 89,832 |
| Total liabilities and stockholders’ equity | $763,271 | $280,406 |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's total liabilities & equity?
- Nektar Therapeutics (NKTR) reported total liabilities & equity of $763.27M in Q1 2026.
- How has Nektar Therapeutics's total liabilities & equity changed year-over-year?
- Nektar Therapeutics's total liabilities & equity increased by 197.9% year-over-year, from $256.24M to $763.27M.
- What is the long-term trend for Nektar Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Nektar Therapeutics's total liabilities & equity has grown at a -28.9% compound annual growth rate (CAGR), from $1.54B to $280.41M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Nektar Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude